Quarterly report pursuant to Section 13 or 15(d)

Notes Payable (Detail Narrative 1)

v3.2.0.727
Notes Payable (Detail Narrative 1)
 1 Months Ended
Nov. 30, 2010
USD ($)
Number
shares
Jun. 30, 2015
USD ($)
Debt Instrument [Line Items]    
Description of unit

Units consisting of a junior secured note and one share of the Company’s common stock.

  
Number of unit issued 10,714,286  
Common stock fair value | $ $ 2,775,300  
Unamortized discount | $   $ (3,124,402)
Officer [Member]    
Debt Instrument [Line Items]    
Number of unit issued 882,726  
Number of officers and directors | Number 4  
Value of unit issued 247,164  
Non-Employee Directors [Member]    
Debt Instrument [Line Items]    
Number of unit issued 567,203  
Number of officers and directors | Number 3  
Value of unit issued 158,816  
2010 Junior Secured Notes Payable [Member]    
Debt Instrument [Line Items]    
Debt face amount | $ $ 3,000,000  
Description of maturity date

Mature in November 2020

  
Stated interest rate 3.50%  
Description of collateral terms

Secured by a security interest in the assets of the Company, which security interest is junior and subordinate to the security interests that secure the Brainlab Note and the 2014 Secured Notes.

  
Description of payment terms

Principal and interest on the junior secured notes will be due and payable in a single payment upon maturity.

  
Unamortized discount | $ $ 2,775,300